PDL BioPharma Inc. (PDLI)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
03-Feb-21 5:57 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 01-Feb-21Private Purchase 187,061$2.05$383,475.00< 1%
23.78M to 23.97M
31-Dec-20 6:48 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 30-Dec-20Private Sale 20,000$2.74$54,800.00(94%)
21.39K to 1.39K
10%
04-Jan-21 5:10 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 30-Dec-20Market Purchase 6,325,210$2.50$15,813,000.0036%
17.46M to 23.78M
(1%)
29-Dec-20 4:56 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 29-Dec-20Market Purchase 268,600$2.69$722,534.002%
17.19M to 17.46M
< 1%
29-Dec-20 4:56 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 28-Dec-20Market Purchase 235,000$2.70$634,500.001%
16.95M to 17.19M
(< 1%)
29-Dec-20 4:56 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 24-Dec-20Market Purchase 128,000$2.65$339,200.00< 1%
16.83M to 16.95M
2%
23-Dec-20 5:50 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 23-Dec-20Market Purchase 485,000$2.60$1,261,000.003%
16.34M to 16.83M
4%
23-Dec-20 5:50 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 22-Dec-20Market Purchase 850,000$2.59$2,201,500.005%
15.49M to 16.34M
4%
22-Dec-20 7:51 PM
View: 
McLaughlin John Peter
Director
PDL BioPharma Inc. (PDLI) 22-Dec-20Market Sale 277,934$2.61$724,574.00(58%)
477.93K to 200.0K
(4%)
23-Dec-20 5:50 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 21-Dec-20Market Purchase 230,000$2.63$604,900.002%
15.26M to 15.49M
3%
22-Dec-20 7:51 PM
View: 
McLaughlin John Peter
Director
PDL BioPharma Inc. (PDLI) 21-Dec-20Market Sale 50,000$2.62$131,200.00(9%)
527.93K to 477.93K
(3%)
18-Dec-20 5:35 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 17-Dec-20Market Purchase 398,000$2.61$1,038,780.003%
14.86M to 15.26M
4%
18-Dec-20 5:35 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 16-Dec-20Market Purchase 1,350,000$2.58$3,483,000.0010%
13.51M to 14.86M
5%
17-Dec-20 4:48 PM
View: 
Monnet Dominique
President and CEO
PDL BioPharma Inc. (PDLI) 16-Dec-20Market Sale 500,000$2.60$1,300,000.00(40%)
1.23M to 734.92K
(4%)
17-Dec-20 4:49 PM
View: 
Stone Christopher Lewis
VP, Gen. Counsel & Secretary
PDL BioPharma Inc. (PDLI) 16-Dec-20Market Sale 200,000$2.56$512,000.00(33%)
605.56K to 405.56K
(6%)
17-Dec-20 4:48 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 16-Dec-20Market Sale 75,000$2.68$201,000.00(78%)
96.39K to 21.39K
(< 1%)
15-Dec-20 7:00 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 15-Dec-20Market Purchase 1,000,000$2.59$2,590,000.008%
12.51M to 13.51M
4%
15-Dec-20 7:00 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 14-Dec-20Market Purchase 640,000$2.62$1,676,800.005%
11.87M to 12.51M
3%
15-Dec-20 7:00 PM
View: 
Silver Point Capital L.P.
10% Owner
PDL BioPharma Inc. (PDLI) 11-Dec-20Market Purchase 450,000$2.45$1,102,500.004%
11.42M to 11.87M
10%
09-Dec-20 7:46 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 05-Dec-20Option Exercise 66,050$1.64$108,322.00218%
30.34K to 96.39K
04-Dec-20 9:17 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 03-Dec-20Market Sale 75,000$2.52$189,000.00(71%)
105.34K to 30.34K
(7%)
04-Dec-20 9:17 PM
View: 
Stone Christopher Lewis
VP, Gen. Counsel & Secretary
PDL BioPharma Inc. (PDLI) 02-Dec-20Disposition 11,544----(2%)
617.1K to 605.56K
24-Nov-20 7:25 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 23-Nov-20Market Sale 50,000$2.43$121,500.00(32%)
155.34K to 105.34K
(11%)
24-Nov-20 7:25 PM
View: 
O'Farrell Elizabeth G.
Director
PDL BioPharma Inc. (PDLI) 23-Nov-20Market Sale 25,826$2.44$63,015.40(100%)
25.83K to 0
(11%)
20-Nov-20 8:22 PM
View: 
Bazaar Alan Lee
Director
PDL BioPharma Inc. (PDLI) 20-Nov-20Market Option Sale 33,435$2.42$81,003.00(76%)
43.87K to 10.44K
(12%)
20-Nov-20 8:22 PM
View: 
Bazaar Alan Lee
Director
PDL BioPharma Inc. (PDLI) 18-Nov-20Option Exercise 37,080$1.71$63,406.80111%
33.44K to 70.52K
20-Nov-20 8:22 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 18-Nov-20Option Exercise 60,000$1.64$98,400.0063%
95.34K to 155.34K
19-Nov-20 5:33 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 18-Nov-20Market Sale 50,000$2.39$119,500.00(34%)
145.34K to 95.34K
(13%)
20-Nov-20 8:22 PM
View: 
O'Farrell Elizabeth G.
Director
PDL BioPharma Inc. (PDLI) 18-Nov-20Market Sale 63,291$2.38$150,696.00(71%)
89.12K to 25.83K
(14%)
20-Nov-20 8:22 PM
View: 
Bazaar Alan Lee
Director
PDL BioPharma Inc. (PDLI) 18-Nov-20Payment of Exercise 26,642$2.38$63,408.00(38%)
70.52K to 43.87K
(14%)
19-Nov-20 5:33 PM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 17-Nov-20Market Sale 100,000$2.40$240,000.00(41%)
245.34K to 145.34K
(13%)
24-Aug-20 6:06 AM
View: 
Hernday Natasha
Director
PDL BioPharma Inc. (PDLI) 19-Aug-20Grant 25,826----52%
50.0K to 75.83K
24-Aug-20 6:05 AM
View: 
Gryska David W
Director
PDL BioPharma Inc. (PDLI) 19-Aug-20Grant 25,826----12%
219.51K to 245.34K
24-Aug-20 6:05 AM
View: 
O'Farrell Elizabeth G.
Director
PDL BioPharma Inc. (PDLI) 19-Aug-20Grant 25,826----41%
63.29K to 89.12K
24-Aug-20 6:06 AM
View: 
McLaughlin John Peter
Director
PDL BioPharma Inc. (PDLI) 19-Aug-20Grant 25,826----5%
502.11K to 527.93K
24-Aug-20 6:05 AM
View: 
Bazaar Alan Lee
Director
PDL BioPharma Inc. (PDLI) 19-Aug-20Grant 25,826----339%
7.61K to 33.44K
21-Apr-20 9:53 PM
View: 
Bazaar Alan Lee
Director
PDL BioPharma Inc. (PDLI) 17-Apr-20Grant 7,609----100%
0 to 7.61K
07-Apr-20 8:45 AM
View: 
Monnet Dominique
President and CEO
PDL BioPharma Inc. (PDLI) 07-Feb-20Payment of Exercise 672,505$3.51$2,360,490.00(35%)
1.91M to 1.23M
25%
07-Apr-20 8:46 AM
View: 
Imbrogno Edward
VP Finance, CAO and Acting CFO
PDL BioPharma Inc. (PDLI) 07-Feb-20Payment of Exercise 82,488$3.51$289,533.00(26%)
314.56K to 232.08K
25%
10-Jan-20 6:37 PM
View: 
Imbrogno Edward
VP Finance, CAO and Acting CFO
PDL BioPharma Inc. (PDLI) 08-Jan-20Grant 292,208----1307%
22.36K to 314.56K
10-Jan-20 6:36 PM
View: 
Jene Jill M.
VP, Business Development
PDL BioPharma Inc. (PDLI) 08-Jan-20Grant 194,805----100%
0 to 194.81K
10-Jan-20 6:36 PM
View: 
Monnet Dominique
President and CEO
PDL BioPharma Inc. (PDLI) 08-Jan-20Grant 1,233,770----183%
673.66K to 1.91M
10-Jan-20 6:36 PM
View: 
Stone Christopher Lewis
VP, Gen. Counsel & Secretary
PDL BioPharma Inc. (PDLI) 08-Jan-20Grant 422,078----212%
198.95K to 621.03K
07-Apr-20 8:48 AM
View: 
Stone Christopher Lewis
VP, Gen. Counsel & Secretary
PDL BioPharma Inc. (PDLI) 16-Dec-19Payment of Exercise 2,686$3.33$8,944.38(< 1%)
619.79K to 617.1K
21%
07-Apr-20 8:48 AM
View: 
Stone Christopher Lewis
VP, Gen. Counsel & Secretary
PDL BioPharma Inc. (PDLI) 12-Dec-19Payment of Exercise 1,240$3.43$4,253.20(< 1%)
621.03K to 619.79K
23%
24-Jun-19 9:41 PM
View: 
Hernday Natasha
Director
PDL BioPharma Inc. (PDLI) 20-Jun-19Grant 50,000----100%
0 to 50.0K
01-Apr-19 5:11 PM
View: 
Monnet Dominique
President and CEO
PDL BioPharma Inc. (PDLI) 28-Mar-19Grant 431,317$3.72$1,604,500.00194%
222.59K to 653.9K
(29%)
09-Jan-19 10:26 AM
View: 
McLaughlin John Peter
CEO
PDL BioPharma Inc. (PDLI) 31-Dec-18Disposition 123,449----(20%)
625.56K to 502.11K
28-Dec-18 6:30 PM
View: 
Garcia Peter S
Vice President, CFO
PDL BioPharma Inc. (PDLI) 27-Dec-18Payment of Exercise 3,553$3.02$10,730.10(2%)
228.58K to 225.03K
28-Dec-18 6:29 PM
View: 
Stone Christopher Lewis
VP, Gen. Counsel & Secretary
PDL BioPharma Inc. (PDLI) 27-Dec-18Payment of Exercise 3,581$3.02$10,814.60(2%)
202.53K to 198.95K